According to the report published by Allied Market Research, the global angiography devices market generated $8.8 billion in 2021, and is projected to reach $15.9 billion by 2031, growing at a CAGR of 6% from 2022 to 2031. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.
Key Takeaways:
- Rise in occurrence of cardiovascular disorders such as heart attacks and atherosclerosis disease.
- Unhealthy lifestyle, high intake of alcohol, stressful and hectic lifestyle, and rise in use of steroids & supplements cause heart attacks.
- Lack of skilled professional, poor reimbursement policies, and high cost of angiography devices.
- Increase in demand for minimally invasive procedures.
Request Sample Copy of Report:
https://www.alliedmarketresearch.com/request-sample/2854
COVID-19 Scenario:
- The outbreak of the COVID-19 had a negative impact on the growth of the global angiography devices market, owing to the postponement of surgeries in cardiac patients during the COVID-19 pandemic.
- Moreover, non-essential surgeries took a potential backlog due to rapid increase in the number of COVID-19 patients, thereby severely impeding the growth of the global market.
Market Segmentation:
Type of Angiography:
Diagnostic Angiography: Devices used primarily for diagnostic purposes to visualize blood vessels and identify blockages, aneurysms, or other vascular abnormalities.
Interventional Angiography: Devices used for interventional procedures such as angioplasty, stent placement, embolization, or thrombolysis to treat vascular conditions.
Technology:
Digital Subtraction Angiography (DSA): A digital imaging technique that enhances the visibility of blood vessels by subtracting the background structures, providing high-quality images.
Computed Tomography Angiography (CTA): CT scanners are used to obtain three-dimensional images of blood vessels for diagnosis and treatment planning.
Magnetic Resonance Angiography (MRA): MRI machines create detailed images of blood vessels without using ionizing radiation.
Catheter Angiography: Traditional catheter-based angiography using contrast media and X-rays for real-time imaging.
Non-Invasive Angiography: Imaging techniques that do not require catheterization, such as Doppler ultrasound or CT/MRI angiography.
Application:
Cardiology: Angiography devices used in the diagnosis and treatment of heart-related conditions.
Neurology: Devices for imaging and treating vascular conditions in the brain and central nervous system.
Oncology: Used for detecting and treating vascular abnormalities associated with tumors.
Peripheral Vascular Disease: Devices for diagnosing and treating conditions affecting the peripheral arteries and veins.
Gastrointestinal Angiography: Used in the assessment and treatment of gastrointestinal bleeding and other vascular conditions.
End-User:
Hospitals: The primary end-users of angiography devices, where diagnostic and interventional procedures are conducted.
Ambulatory Surgical Centers (ASCs): Outpatient facilities that perform angiography procedures.
Diagnostic Imaging Centers: Specialized centers offering angiography services. Research and Academic Institutions:
Angiography devices may be used for research and teaching purposes.
Geography:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest Of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest Of Asia-Pacific)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest Of LAMEA)
Request for Customization:
https://www.alliedmarketresearch.com/request-for-customization/2854
Regional Growth Dynamics:
The market across the Asia-Pacific region held the major market share in 2021, holding more than one-third of the global angiography devices market share, and is expected to maintain its leadership status during the forecast period. In addition, the same region is expected to cite the fastest CAGR of 6.7% during the forecast period. The report also analyses other regions such as Europe, North America, and LAMEA.
Key findings of the study:
- By product type, the angiography systems segment was the highest contributor to the market in 2021.
- By application, the diagnostic was the highest contributor to the market in 2021.
- By technology, the X-Ray angiography segment dominated the market in 2021.
- By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Competitive Landscape:
Merit Medical Systems, Inc., Siemens Healthcare, General Electric Company, Boston Scientific Corporation, AngioDynamics, Inc., Medtronic, Inc., b.braun melsungen ag, Koninklijke Philips N.V., Abbott Laboratories, shimadzu corporation
Trending Reports in Healthcare Industry-
Radiodermatitis Market – Global Opportunity Analysis and Industry Forecast, 2020–2030
Thyroid Ablation Devices Market – Global Opportunity Analysis and Industry Forecast, 2020-2030
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter